Reading many papers I´ve found that in this context (cell proliferation) using metabolic assays such as MTT is like "the gold standard". Many papers use this approach when trying to determine inhibition of proliferation of an anticancer drug, but i have also noticed that many persons from the scientific community say that this is not the best approach and that a DNA dye-based assay will be more "representative" of cell proliferation inhibition.

I´ll like to know which is your opinion in this regard and what you will recommend using and why.

I´m working with antiandrogens in cancer cell lines.

More Mauricio de la Rosa's questions See All
Similar questions and discussions